225 related articles for article (PubMed ID: 31372677)
1. [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].
Gockel I; Lordick F; Lyros O; Kreuser N; Hölscher AH; Wittekind C
Chirurg; 2020 Jan; 91(1):41-50. PubMed ID: 31372677
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
[TBL] [Abstract][Full Text] [Related]
4. Cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
6. Esophageal and esophagogastric junction cancers, version 1.2015.
Ajani JA; D'Amico TA; Almhanna K; Bentrem DJ; Besh S; Chao J; Das P; Denlinger C; Fanta P; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Jasperson K; Keswani RN; Kleinberg LR; Korn WM; Leong S; Lockhart AC; Mulcahy MF; Orringer MB; Posey JA; Poultsides GA; Sasson AR; Scott WJ; Strong VE; Varghese TK; Washington MK; Willett CG; Wright CD; Zelman D; McMillian N; Sundar H;
J Natl Compr Canc Netw; 2015 Feb; 13(2):194-227. PubMed ID: 25691612
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
8. Esophagogastric junction carcinoma: introduction.
Goodman KA
Semin Radiat Oncol; 2013 Jan; 23(1):1-2. PubMed ID: 23207040
[No Abstract] [Full Text] [Related]
9. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
[TBL] [Abstract][Full Text] [Related]
10. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.
Suh YS; Han DS; Kong SH; Lee HJ; Kim YT; Kim WH; Lee KU; Yang HK
Ann Surg; 2012 May; 255(5):908-15. PubMed ID: 22504190
[TBL] [Abstract][Full Text] [Related]
11. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
Kim HI; Cheong JH; Song KJ; An JY; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2013 Aug; 20(8):2713-20. PubMed ID: 23456315
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Therapeutic Implications of the 8th Edition TNM Classification of Adenocarcinomas of the Esophagogastric Junction.
Birla R; Gandea C; Hoara P; Caragui A; Marica C; Vasiliu E; Constantinoiu S
Chirurgia (Bucur); 2018; 113(6):747-757. PubMed ID: 30596362
[TBL] [Abstract][Full Text] [Related]
13. Considering the esophagogastric junction as a 'zone'.
Ichihara S; Uedo N; Gotoda T
Dig Endosc; 2017 Apr; 29 Suppl 2():3-10. PubMed ID: 28425656
[TBL] [Abstract][Full Text] [Related]
14. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
[TBL] [Abstract][Full Text] [Related]
15. Updates in the 8th edition of the TNM staging system for esophagus and esophagogastric junction cancer.
Daiko H; Kato K
Jpn J Clin Oncol; 2020 Aug; 50(8):847-851. PubMed ID: 32519741
[TBL] [Abstract][Full Text] [Related]
16. Siewert III adenocarcinoma: treatment update.
Di Leo A; Zanoni A
Updates Surg; 2017 Sep; 69(3):319-325. PubMed ID: 28303519
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches to gastroesophageal junction adenocarcinomas.
Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R
Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026
[TBL] [Abstract][Full Text] [Related]
18. [Multimodality therapy for adenocarcinoma of the esophagogastric junction].
He J; Huang JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):877-80. PubMed ID: 22990915
[TBL] [Abstract][Full Text] [Related]
19. Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico.
Oñate-Ocaña LF; Milán-Revollo G; Aiello-Crocifoglio V; Carrillo JF; Gallardo-Rincón D; Brom-Valladares R; Herrera-Goepfert R; Dueñas-González A
Ann Surg Oncol; 2007 Apr; 14(4):1439-48. PubMed ID: 17235713
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
